| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/05/2001 | CA2385888A1 Engineering antibodies that bind irreversibly |
| 04/05/2001 | CA2384981A1 P-glycoproteins and uses thereof |
| 04/05/2001 | CA2384814A1 Methods for rapid peg-modification of viral vectors, compositions for enhanced gene transduction, compositions with enhanced physical stability, and uses therefor |
| 04/05/2001 | CA2384723A1 Vaccine |
| 04/05/2001 | CA2384659A1 37 human secreted proteins |
| 04/05/2001 | CA2384382A1 Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus |
| 04/05/2001 | CA2379623A1 Immunologically significant herpes simplex virus antigens |
| 04/05/2001 | CA2304377A1 Peptide repeat immunogens |
| 04/04/2001 | EP1088900A1 Polymorphisms in the human CYP3A4, CYP3A7 and hPXR genes and their use in diagnostic and therapeutic applications |
| 04/04/2001 | EP1088830A2 Hepatitis b surface antigen particles |
| 04/04/2001 | EP1088557A1 Immunisation against cancer with mutated p53 |
| 04/04/2001 | EP1088092A1 Replication-defective recombinant adenovirus with mutated major late promoter |
| 04/04/2001 | EP1088077A1 Newcastle disease virus infectious clones, vaccines and diagnostic assays |
| 04/04/2001 | EP1088075A2 Aav scleroprotein, production and use thereof |
| 04/04/2001 | EP1088072A2 Prostate cancer-associated genes |
| 04/04/2001 | EP1088071A1 94 human secreted proteins |
| 04/04/2001 | EP1087997A2 Monoclonal antibodies directed against the g3bp protein, and uses |
| 04/04/2001 | EP1087994A1 INTERACTION OF p27(KIP1) WITH FKBP-12 |
| 04/04/2001 | EP1087941A2 Thiolesters and uses thereof |
| 04/04/2001 | EP1087792A1 NrdD |
| 04/04/2001 | EP1087791A1 Inhibition of xenoreactive antibodies |
| 04/04/2001 | EP1087789A2 Use of poxviruses as enhancer of specific immunity |
| 04/04/2001 | EP1087788A1 Mucosal targeting immunisation |
| 04/04/2001 | EP1087787A1 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic lhrh peptides |
| 04/04/2001 | EP1087786A1 Methods and materials for the treatment of prostatic carcinoma |
| 04/04/2001 | EP1087784A1 Synthetic somatostatin immunogen for growth promotion in farm animals |
| 04/04/2001 | CN1290176A Direct cytotoxic activity by anti-hCG monoclonal antibodies |
| 04/04/2001 | CN1290175A Live vaccine for human immunodeficiency virus |
| 04/04/2001 | CN1290174A Compositions and methods for systemic delivery of oral vaccines and therapeutic agents |
| 04/04/2001 | CN1290173A Over-expressing homologous antigen vaccine and method of making same |
| 04/04/2001 | CN1289621A Process for preparing hypotoxic vaccine for vincs of young parakeet |
| 04/04/2001 | CN1289598A Veterinary medicine for treating infective serositis of duck and its preparing process |
| 04/04/2001 | CN1063971C Method for preparing freeze-dried live vaccine for animal use |
| 04/04/2001 | CN1063970C Epidemic encephalitis B vaccine and preparation by using lepidoptera mybhimua separata ovary cells |
| 04/03/2001 | US6211352 Method for the diagnosis and treatment of glutamic acid decarboxylase autoantigen associated diseases |
| 04/03/2001 | US6211343 Lactoferrin receptor protein |
| 04/03/2001 | US6211338 Single-chain recombinant complexes of hepatitis C virus NS3 protease and NS4A cofactor peptide |
| 04/03/2001 | US6211159 Flagellin gene, FlaC of campylobacter |
| 04/03/2001 | US6211148 Antimicrobial peptides from bovine neutrophis |
| 04/03/2001 | US6210974 Compositions and methods for promoting nerve regeneration |
| 04/03/2001 | US6210968 DNA molecules encoding pgp3 protein from Chlamydia trachomatis |
| 04/03/2001 | US6210962 Nucleotide and peptide sequences of an isolate of the hepatitis C virus, diagnostic and therapeutic applications thereof |
| 04/03/2001 | US6210948 Nucleotide sequence coding a bacterial protein; for utilization in bioreactors |
| 04/03/2001 | US6210944 Phosphoribosyl transferase from Staphylococcus aureus |
| 04/03/2001 | US6210926 Activating apoptosis in cell infected with herpes by in vitro administration of agent that inhibits infected cell protein-4 function |
| 04/03/2001 | US6210920 Flea protease proteins, nucleic acid molecules, and uses thereof |
| 04/03/2001 | US6210903 Amino acid sequence which is optionally modified and biotinylated |
| 04/03/2001 | US6210901 Modified hepatitis c virus amino acid sequence which binds to an antibody; for screening blood samples |
| 04/03/2001 | US6210874 Synthetic peptides and mixtures thereof for detecting HIV antibodies |
| 04/03/2001 | US6210873 Methods and compositions for the priming of specific cytotoxic T-lymphocyte response |
| 04/03/2001 | US6210718 Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals |
| 04/03/2001 | US6210685 Acellular whooping cough vaccines. |
| 04/03/2001 | US6210684 Method for delaying the onset of AIDS |
| 04/03/2001 | US6210683 Stabilizers containing recombinant human serum albumin for live virus vaccines |
| 04/03/2001 | US6210682 Immunization against rotavirus infection or rotavirus disease by administering to a subject a peptide nsp4 114-135, a peptide nsp4 120-147, or a toxoid thereof are disclosed. |
| 04/03/2001 | US6210676 Compositions and methods using the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein C (OspC) for the diagnosis and prevention of lyme disease |
| 04/03/2001 | US6210675 Post-transfusional non-a non-b hepatitis viral polypeptide |
| 04/03/2001 | US6210674 GreA from Staphylococcus aureus |
| 04/03/2001 | US6210673 gidB from Staphylococcus aureus |
| 04/03/2001 | US6210672 Topical immunostimulation to induce Langerhans cell migration |
| 04/03/2001 | US6210670 Cross-reacting monoclonal antibodies specific for E-selectin and P-selectin |
| 04/03/2001 | US6210669 Methods and compositions for immunomodulation |
| 04/03/2001 | US6210663 Priming vaccine compriseing dna sequence encoding an antigen of a pathogen under control of regulatory sequences directing expression; administering intranasally boosting vaccine composition which comprises the same antigen in protein form |
| 04/03/2001 | US6210662 Fusion protein having prostatic acid phosphatase (pap) as an n-terminal moiety and gm-csf as a c-terminal moiety, and wherein said cells are effective to activate t-cells to produce a multivalent cytotoxic cellular immune response |
| 04/03/2001 | US6210661 IL-4 receptor for the therapy, prophylaxis and diagnosis of allergic, viral, and bacterial diseases and of fungal infections |
| 04/03/2001 | CA2153180C Interleukin 4 signal transducers and binding assays |
| 03/30/2001 | CA2283538A1 New hev antigenic peptide and methods |
| 03/29/2001 | WO2001021811A1 Dna immunization against chlamydia infection |
| 03/29/2001 | WO2001021810A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 03/29/2001 | WO2001021806A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 03/29/2001 | WO2001021804A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 03/29/2001 | WO2001021803A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 03/29/2001 | WO2001021802A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 03/29/2001 | WO2001021799A1 Traf4 associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | WO2001021796A2 Gl50 molecules and uses therefor |
| 03/29/2001 | WO2001021784A2 Pcna-associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | WO2001021773A2 Human endothelin converting enzyme-like proteins and polynucleotides encoding the same |
| 03/29/2001 | WO2001021764A1 A pcra helicase of staphylococcus aureus |
| 03/29/2001 | WO2001021663A1 Pcna associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | WO2001021658A1 32 human secreted proteins |
| 03/29/2001 | WO2001021656A2 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors |
| 03/29/2001 | WO2001021655A2 Virulence gene and protein, and their use |
| 03/29/2001 | WO2001021653A2 Ovarian tumor antigen and methods of use therefor |
| 03/29/2001 | WO2001021651A2 Novel human protease inhibitor-like proteins and polynucleotides encoding the same |
| 03/29/2001 | WO2001021636A1 Identification of a vaccine candidate from an extraintestinal isolate of e. coli |
| 03/29/2001 | WO2001021213A2 Inhibition of secretion from non-neuronal cells |
| 03/29/2001 | WO2001021207A2 Use of combination of polyoxyethylene sorbitan ester and octoxynol as adjuvant and its use in vaccines |
| 03/29/2001 | WO2001021204A1 Therapeutic uses of m3 polypeptide |
| 03/29/2001 | WO2001021203A1 Use of an outer membrane protein a of an enterobacterium associated with a rsv immunogenic peptide for preparing vaccines for intranasal administration |
| 03/29/2001 | WO2001021202A2 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells |
| 03/29/2001 | WO2001021201A2 Use of replication-deficient adenoviral vector to boost cd8+ t cell immune response to antigen |
| 03/29/2001 | WO2001021200A1 Oral recombinant lactobacilli vaccines |
| 03/29/2001 | WO2001021199A1 Highly efficient dendritic cell-targeted dna-vaccination |
| 03/29/2001 | WO2001021196A1 Method and compositions for inhibiting adhesion formation |
| 03/29/2001 | WO2001021193A1 Hybrid peptides modulate the immune response |
| 03/29/2001 | WO2001021192A2 Methods for diagnosis and therapy of hematological and virus-associated malignancies |
| 03/29/2001 | WO2001021189A1 Inducing cellular immune responses to hepatitis c virus using peptide and nucleic acid compositions |
| 03/29/2001 | WO2001021152A1 Adjuvant comprising a polyxyethylene alkyl ether or ester and at least one nonionic surfactant |
| 03/29/2001 | WO2001021151A1 Intranasal influenza virus vaccine |
| 03/29/2001 | WO2001002557A8 Neurotrophic factor receptor |